Third Arc Bio | Biotech | Standout | Standout

Third Arc Bio

37 employees

Biotech

Series A · $217.0M

Open positions (1)

Director, Discovery and CMC Program Management

Bengaluru, Karnataka

Company details

Team Size37

IndustryBiotech

Funding

Total raised

$217.0M

Last stage

Series A

Investors

Andreessen Horowitz

Omega Funds

Vida Ventures

StandoutYBacked by Y Combinator · P26

“LeBron has an agent. Why don’t you?”

— Now you have one too.

Earn $3,000

ProductHow it works For talent For companies Browse jobs Browse companies

CompanyAbout Blog Careers

ConnectTwitter / X LinkedIn

Standout.

Privacy Terms

Cormorant Asset Management

Hillhouse Investment

Founders

Sanjaya Singh

PhD in molecular biology; co-inventor of Risankizumab (Skyrizi) and other immunology/oncology compounds; former Global Head of Janssen Biotherapeutics at J&J; founded Third Arc Bio in 2022.

Peter F. Lebowitz

MD, PhD; joined Third Arc Bio as CEO in January 2024; former Global Head of Oncology R&D at Johnson & Johnson, where he oversaw 13 major drug approvals.

Joe Erhardt

PhD; joined Third Arc Bio in 2023; formerly VP and Global Head of Oncology Discovery and External Innovation at Johnson & Johnson.

What happens next.

No applications, no recruiter spam. Just the intro.

Confirm the fit

A few questions to make sure this role is the right shape for you. Two minutes.

I pitch you to the company

I write the intro, send it to the founder, and handle the back-and-forth.

A meeting lands on your calendar

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.